Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Arkansas
M.D. Anderson Cancer Center
Medical College of Wisconsin
University of Alabama at Birmingham
Stichting Hemato-Oncologie voor Volwassenen Nederland
University Hospital, Lille
City of Hope Medical Center
University of Turin, Italy
Thomas Jefferson University
University of Rochester
University of Arkansas
Weill Medical College of Cornell University
Washington University School of Medicine
Janssen Research & Development, LLC
University of Arkansas
University of Arkansas
University of Arkansas
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Emory University
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Memorial Sloan Kettering Cancer Center